|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||
|
||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s8C9817C0-6007-11EF-9685-20DA84CE164B&I=39IZM&T=&OP=Display&O=html&O1=15845104&O2=1000000000294757&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DSoluble%2520expression%2520and%2520activity%2520evaluation%2520of%2520SDF-1%252F54R%252C%2520a%2520specific%2520antagonist%2520of%2520CXCR7%26rft.au%3DCao%252C%2520Yuanzhi%26rft.date%3D2014-06-01%26rft.externalDocID%3D24968837%26rft.genre%3Darticle%26rft.issn%3D1673-4254%26rft.issue%3D6%26rft.jtitle%3DNan%2520fang%2520yi%2520ke%2520da%2520xue%2520xue%2520bao%2520%253D%2520Journal%2520of%2520Southern%2520Medical%2520University%26rft.spage%3D818%26rft.volume%3D34%26rft_id%3Dinfo%253Apmid%252F24968837%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MESSAGE_NO_FULLTXT_LCL-getMessageNoFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,4-REFWORKS_EXPORT_TOOL-getReference-object,5-NCBI_PUBMED_FREE-getCitedRecord-object,6-GOOGLE_SCHOLAR_FREE-getWebSearch-object,7-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.014793&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15845104-s8C9817C0-6007-11EF-9685-20DA84CE164B" timestamp="2024-08-21T23:51:41Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:1000000000294757</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>[Soluble expression and activity evaluation of SDF-1/54R, a specific antagonist of CXCR7].</jnl:atitle>
<jnl:jtitle>南方医科大学学报</jnl:jtitle>
<jnl:date>2014-06-00</jnl:date>
<jnl:spage>818</jnl:spage>
<jnl:epage>822</jnl:epage>
<jnl:issn>1673-4254</jnl:issn>
<jnl:volume>34</jnl:volume>
<jnl:issue>6</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2663-0842</jnl:eissn>
<jnl:language>chi</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:1fb19c9dfe2415db43d6b15aa697b5b82771e79a</ctx:identifier>
<ctx:identifier>urn:UUID:s8C9817C0-6007-11EF-9685-20DA84CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)